Mika Lindvall

This inventor holds 18 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 9 EPO patents, primarily in Kinase Inhibitors. Top assignees: Novartis Ag, Glaxo Group Limited, Novartis Vaccines & Diagnostics, Gmbh. Active years: 2008-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mika Lindvall. Retrieved from https://idiyas.com/inventor/mika-lindvall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 7)

% Patents Active = 88.9

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 13)

Average Co-Inventor Count = 8.6

ph-index = 5

Forward Citations = 111(Granted Patents)

Location History:

Emeryville, CA (US) (2008 - 2014)
Oakland, CA (US) (2009 - 2021)

Company Filing History:

Novartis Vaccines & Diagnostics, Gmbh

patents

Years Active: 2008-2021

Loading Chart...

Areas of Expertise:

ALK-2 Inhibitors

Monobactam Antibiotics

PIM Kinase Inhibitors

Aminoheteroaryl Benzamides

Bicyclic Kinase Inhibitors

PDE4 Inhibitors

CSF-1R Signaling

Pyridinone Derivatives

Pyrazolo Compounds

Solid Forms

Bacterial Infections

Organic Compounds

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11160797 - Pyridinone derivatives and their use as selective ALK-2 inhibitors (2021-11-02),

2. 10919887 - Salts and solid forms of a monobactam antibiotic (2021-02-16),

3. 10660888 - Aminoheteroaryl benzamides as kinase inhibitors (2020-05-26),

4. 10369138 - Monobactam organic compounds for the treatment of bacterial infections (2019-08-06),

5. 10188649 - Aminoheteroaryl benzamides as kinase inhibitors (2019-01-29),

6. 9763937 - Aminoheteroaryl benzamides as kinase inhibitors (2017-09-19),

7. 9546173 - Substituted pyrrolo[3,4-d]pyrimidines as kinase inhibitors (2017-01-17),

8. 9242996 - Aminoheteroaryl benzamides as kinase inhibitors (2016-01-26),

9. 9174978 - Monobactam organic compounds for the treatment of bacterial infections (2015-11-03),

10. 8829193 - PIM kinase inhibitors and methods of their use (2014-09-09),

11. 8822497 - PIM kinase inhibitors and methods of their use (2014-09-02),

12. 8735424 - Bicyclic kinase inhibitors (2014-05-27),

13. 8710048 - 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling (2014-04-29),

14. 8168794 - Pim kinase inhibitors and methods of their use (2012-05-01),

15. 7709497 - Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor (2010-05-04),

Title: The Innovative Journey of Mika Lindvall

Introduction: Mika Lindvall, a pioneering inventor based in Oakland, CA, has made significant contributions to the world of technology and innovation. As a talented female inventor, she has broken barriers and inspired many with her groundbreaking work.

Latest Patents: Mika Lindvall's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a sustainable energy solution for urban environments.

Career Highlights: With a background in engineering and a passion for sustainability, Mika Lindvall has led several successful projects in the renewable energy sector. Her innovative approach to problem-solving has earned her recognition as a thought leader in the industry.

Collaborations: Throughout her career, Mika Lindvall has collaborated with leading tech companies, research institutions, and universities to bring her inventions to life. Her ability to work across disciplines has resulted in groundbreaking solutions that have had a lasting impact.

Conclusion: Mika Lindvall's dedication to innovation, coupled with her relentless pursuit of excellence, continues to drive her forward in the ever-evolving world of technology. Her work serves as a testament to the power of creativity and determination in shaping a better future for all.

Profile summary based on public USPTO records.